CDK4/6 inhibitors for metastatic breast cancer in routine clinical practice in Spain: survey of patterns of use and oncologists’ perceptions

Fulvestrant Clinical Practice
DOI: 10.1007/s12094-025-03896-z Publication Date: 2025-03-30T06:08:00Z